Industry still fears political opposition to European Union GM legislation

Article Abstract:

The biotechnology industry are still concerned about political opposition to genetically modified organisms despite a revision made by the European Parliament on directive 90/220 for the release of GM organisms into the environment.

---

Scientists cry foul as Europe plays politics with GM crops

Article Abstract:

The bioscientists of the European Federation of Biotechnology (EFB, Spain) opposed the unscientific decision of the European Commission for the Environment on the use of genetically modified (GM) organisms (GMOs). The misconception about the environmental hazards of GMO release and the reports about the GM products likely to have any adverse influence on human and animal health or the environment are argued.

Europe, Legal issues & crime, Government regulation (cont), Management dynamics, Legal/Government Regulation, Management, Usage, Laws, regulations and rules, Government regulation, Environmental aspects, European Union. European Commission, Company business management, Genetically modified crops

---

EC says 1% is acceptable GMO "contamination."

Article Abstract:

The European Commission's Standing Committee for Foods has set a legal threshold for accidental inclusion of genetically-modified foods. More maneuvering in the EU will follow before the new level becomes law.

Product standards, safety, & recalls, Government domestic functions, Food & Kindred Products, Food Manufacturing, Product quality

Similar abstracts:

• Abstracts: Industry leaders offer retailers suggestions on keeping pace with change. Creve Coeur Camera
• Abstracts: Valuation conundrum still resonates with open issues despite some recent taxpayer victories. Gifts of FLP interests: two concerns recently addressed
• Abstracts: The dynamics of learning alliances: competition, cooperation, and relative scope. Strategic networks
• Abstracts: New entrants in a mature market: an empirical study of the detergent market. First-store loyalty and retention
• Abstracts: A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.